Literature DB >> 15025902

The quest for well-being: a qualitative study of the experience of taking antipsychotic medication.

Rachael Carrick1, Annie Mitchell, Richard A Powell, Keith Lloyd.   

Abstract

Antipsychotic medication is integral to the treatment of severe and enduring mental health problems (e.g. schizophrenia). Such medication is associated with significant adverse side effects that can affect treatment adherence. To date there have been few attempts to analyse qualitatively service users' experience of taking antipsychotic medication. This study, conducted in Exeter, South West England, investigates the subjective experience of side effects of antipsychotic medication to gain a greater understanding of service users' experiences and to gain insights into adherence issues. Data were analysed using a variant of grounded theory (Glaser and Strauss, 1967) and a model of the experience of taking antipsychotic medication was constructed. The interview schedule was then refined and further interviews (including a focus group) were conducted among a diverse sample recruited from local day centres. Results indicated that people taking antipsychotic medication do not see side effects and symptoms as separate issues. Instead, they describe drugs as 'good' or 'terrible'-an indication of the total impact of their treatment. The model constructed reflects this, having the core concept of Well-being: that is, normality of function, feeling and appearance to the outside world. Major themes relating to this core category were managing treatment, evaluating treatment and understanding of the situation. Implications for medication adherence and clinical practice, including drug choice, are discussed, and the doctor-patient relationship is also considered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025902     DOI: 10.1348/147608304322874236

Source DB:  PubMed          Journal:  Psychol Psychother        ISSN: 1476-0835            Impact factor:   3.915


  18 in total

1.  Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data.

Authors:  Jemima Thompson; Jacki L Stansfeld; Ruth E Cooper; Nicola Morant; Nadia E Crellin; Joanna Moncrieff
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-24       Impact factor: 4.328

2.  The importance of medication in consumer definitions of recovery from serious mental illness: a qualitative study.

Authors:  Myra Piat; Judith Sabetti; David Bloom
Journal:  Issues Ment Health Nurs       Date:  2009-08       Impact factor: 1.835

3.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Authors:  Martijn J Kikkert; Aart H Schene; Maarten W J Koeter; Debbie Robson; Anja Born; Hedda Helm; Michela Nose; Claudia Goss; Graham Thornicroft; Richard J Gray
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

4.  Why do persons with bipolar disorder stop their medication?

Authors:  Kavi K Devulapalli; Rosalinda V Ignacio; Peter Weiden; Kristin A Cassidy; Tiffany D Williams; Roknedin Safavi; Frederic C Blow; Martha Sajatovic
Journal:  Psychopharmacol Bull       Date:  2010

5.  Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.

Authors:  Birgit Janssen; Wolfgang Gaebel; Martin Haerter; F Komaharadi; Birgit Lindel; Stefan Weinmann
Journal:  Psychopharmacology (Berl)       Date:  2006-05-19       Impact factor: 4.530

6.  Medication adherence among older adults with schizophrenia.

Authors:  Heather C Leutwyler; Patrick J Fox; Margaret Wallhagen
Journal:  J Gerontol Nurs       Date:  2013-01-18       Impact factor: 1.254

7.  Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.

Authors:  Michael J Crawford; Lavanya Thana; Rachel Evans; Alexandra Carne; Lesley O'Connell; Amy Claringbold; Arunan Saravanamuthu; Rebecca Case; Jasna Munjiza; Sandra Jayacodi; Joseph G Reilly; Elizabeth Hughes; Zoe Hoare; Barbara Barrett; Verity C Leeson; Carol Paton; Patrick Keown; Sofia Pappa; Charlotte Green; Thomas Re Barnes
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

8.  Subjective Well-Being Under Neuroleptics Scale short form (SWN-K): reliability and validity in an Estonian speaking sample.

Authors:  Liina Haring; René Mõttus; Peeter Jaanson; Raine Pilli; Kairi Mägi; Eduard Maron
Journal:  Ann Gen Psychiatry       Date:  2013-09-11       Impact factor: 3.455

9.  Patients' health literacy in psychotic disorders.

Authors:  Ghassen Saba; Lila Mékaoui; Marion Leboyer; Franck Schürhoff
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

10.  Understanding the meaning of medications for patients: the medication experience.

Authors:  Sarah J Shoemaker; Djenane Ramalho de Oliveira
Journal:  Pharm World Sci       Date:  2007-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.